GORE® ACUSEAL Vascular Graft by Gore Medical
The GORE® ACUSEAL Vascular Graft is a purpose-built hemodialysis access graft designed for early cannulation, allowing dialysis access within 24 hours when clinically appropriate. It provides an immediate vascular access option that may help reduce the need for prolonged central venous catheter use.
Designed for patients who require rapid dialysis access, including those at risk of fistula non-maturation or those already using a central venous catheter, the GORE® ACUSEAL Vascular Graft combines a tri-layer structure, heparin surface technology, and flexible handling for reliable vascular access placement.
Clinical Applications
GORE® ACUSEAL Vascular Graft is used for hemodialysis access when early cannulation and timely vascular access are required.
Hemodialysis Access
- Early cannulation vascular access
- Dialysis access within 24 hours when clinically appropriate
- Support for patients requiring access in under two weeks
CVC Reduction Support
- May support earlier central venous catheter removal
- Option for patients at risk of fistula non-maturation
- Immediate access solution for selected dialysis patients
Key Features
Early Cannulation
Designed to support cannulation within 24 hours when clinically appropriate, helping provide timely hemodialysis access.
Tri-Layer Design
The graft features an elastomeric middle layer that acts as a low-bleed barrier to cannulation needle holes while maintaining practical surgical handling.
CBAS® Heparin Surface Technology
CBAS® Heparin Surface Technology is designed to resist thrombosis, a leading cause of arteriovenous graft failure.
Flexible Construction
Flexible graft construction supports placement around curves while helping reduce the risk of kinking.
Reported Clinical Outcomes
GORE® ACUSEAL Vascular Graft is designed to support earlier access and reduce reliance on central venous catheters in selected patients.
Reduced CVC Risk
- Reported 5× lower risk of infection compared with CVC
- Reported 3× lower risk of mortality compared with CVC
- May reduce cost related to CVC sepsis by enabling earlier CVC removal
Patency and Clot-Free Survival
- Reported 78% secondary patency at 12 months
- Reported 78% clot-free survival at one year
- Designed to support reliable dialysis access outcomes
Available Sizes
| Item Number | Description |
|---|---|
| ECH060040 | 6 mm × 40 cm | Heparin |
| ECH470045 | 4–7 mm × 45 cm | Tapered | Heparin |
Early Cannulation Hemodialysis Access Graft
The GORE® ACUSEAL Vascular Graft provides an early cannulation vascular access solution for selected hemodialysis patients. Its tri-layer low-bleed design, CBAS® Heparin Surface Technology, flexible construction, and available straight or tapered configurations make it suitable for vascular access procedures where rapid dialysis access and reduced CVC dependence are important clinical considerations.